Drugging the P53 Pathway: Understanding the Route to Clinical Efficacy

Nature Reviews Drug Discovery - United Kingdom
doi 10.1038/nrd4288
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

New Perspective on Targeting the Tumor Suppressor P53 Pathway in the Tumor Microenvironment to Enhance the Efficacy of Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Practicalities of Drugging the Phosphatidylinositol-3-Kinase/Akt Cell Survival Signaling Pathway

Clinical Cancer Research
Cancer ResearchOncology
2006English

P53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

Cell
BiochemistryGeneticsMolecular Biology
2019English

The Drugging of the Americas

HAHR - Hispanic American Historical Review
Cultural StudiesHistory
1977English

Evolution of the P53-Mdm2 Pathway

BMC Evolutionary Biology
EvolutionEcologySystematicsBehavior
2017English

Target Watch: Drugging the Epigenome

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2013English

Polymorphisms in P53 and the P53 Pathway: Roles in Cancer Susceptibility and Response to Treatment

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Single-Nucleotide Polymorphisms in the P53 Pathway

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2005English

The Pragmaticism as a Route to Designing: Understanding the Inferential Logics of Sense Attribution

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy